// App-Quantinova.ai

: ECULIZUMAB IN THE TREATMENT OF HYPERHAEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE; A SINGE CENTRE EXPERIENCE

Researchers

Presenter

  • Monica Ragheb

Principal Investigators

  • Annelies Billen

  • Sophie Ganjavian

  • Amrita Saravanan

  • Jo Howard

  • Rachel Kesse-Adu

  • Kate Gardner

  • Nita Prasannan

  • Anicee Danaee

Medical Centers

  • Medical Oncology, Guys and St Thomas NHS Trust, London, United Kingdom

  • Medical Oncology, Guys and St Thomas NHS Trust, London, United Kingdom

  • Medical Oncology, Guys and St Thomas NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

Disease

  • Gastrointestinal bleeding

  • Sickle cell anemia

  • Pulmonary embolism

  • Arrhythmia

  • Renal disease

  • Venous thrombosis

  • Uremia

  • Stroke

Biomarkers

  • Androgen receptor

Drug/Treatment

  • Hydroxycarbamide

  • Erythropoietin

  • Eculizumab

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved